Executive Leadership Team

Manki Song, Ph.D.

Manki Song, Ph.D., is the Deputy Director General of IVI’s Science Unit. He has had a longstanding interest in public health and threats to the health of populations in developing country. In the first years of his career, he focused on viral diseases, particularly HIV, HBV and HCV. Most recently, as the Head of the Clinical Research Lab Department at IVI, he broadened the scope of his studies to include SARS-CoV-2, MERS-CoV, and SFTS vaccine development.

Before joining IVI as a research scientist in 2004, Dr. Song served as an IVI postdoctoral fellow in 2001 at Prof. Myron Levine’s Center for Vaccine Development (CVD) at the University of Maryland School of Medicine in Baltimore, U.S.A. During this period, he focused on the development of new-generation measles vaccines using naked DNA, attenuated Shigella, and Salmonella.

Dr. Song has also actively served on steering committees of many academic societies including the Korea Association of Immunologists and the Korean Vaccine Society. After two years of service as a Review Board member of the Korea National Research Foundation (Immunology in Medical Science), he has been working as a Program Manager of the state-run Korea Health Industry Development Institute (KHIDI) since 2015.

Dr. Song received his B.Sc. degree from Seoul National University, and his M.Sc. and Ph.D. degrees from Pohang University of Science and Technology (POSTECH).